Erratum to: Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study.

Authors: Ruggeri M, Bellasi A, Cipriani F, Molony D, Bell C, Russo D, Di Iorio B
PMID: 25098354 [PubMed - as supplied by publisher] (Source: Journal of Nephrology)